NCT03647098View on ClinicalTrials.gov

Survival Outcomes of Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2030

Conditions
Lung Cancer
Interventions
DRUG

Treatment

Treatment decisions guided by molecular profiling and clinical judgment of principal investigators

Trial Locations (1)

410013

RECRUITING

Hunan Cancer Hospital, Changsha

All Listed Sponsors
lead

Hunan Province Tumor Hospital

OTHER